SuredoseRx™ to launch in first quarter
COLUMBIA, S.C., Jan. 18, 2022 (GLOBE NEWSWIRE) — The Ritedose Corporation has announced the development of and plans to commercialize the first new way to dispense single-dose liquid medications in two decades.
After five years of R&D, the Columbia-based developer of blow-fill-seal unit dose technology is launching SuredoseRx™, an easier and more convenient way for healthcare workers to administer, and patients to take, single doses of liquid medications.
The single-unit doses will be individually wrapped and bar-coded for ease of use by hospitals and other clinical settings.
SuredoseRx will debut with three of the most-used liquid drugs in the first quarter of 2022, followed by rollouts of many others.
Historically, single-dose liquid medications have been supplied in small foil-lidded plastic cups where the seal must be manually pulled off.
In contrast, the Ritedose package is a small low-density polyethylene ampoule with a twist-off top that is designed not to spill. Medication comes out in force only when the ampoule is squeezed. In the event the ampoule is dropped, the design allows for less spillage.
“This resolves problems of accidental spillage that many healthcare providers and patients have experienced with the old-style cups,” said Jody Chastain, CEO of The Ritedose Corporation. “We heard story after story of nurses and patients accidentally dropping the cups after opening them with some of the medication spilling. At that point, you have no way of knowing how much is remaining. SuredoseRx is purposely designed to help prevent these problems, and we think it is a game-changer to make life easier for patients and those who care for them.”
The five years of research and development of SurdoseRx started in a hospital room where Chastain’s wife was being treated for cancer.
He watched as a nurse unsuccessfully struggled to pull the lid off a medication cup. She then cut the top open with scissors as a last resort.
“That one act immediately compromised the drug my wife was supposed to take,” Chastain said. “I asked the nurse to get another cup.”
Based upon that experience, Chastain initiated a research and development project that resulted in a revolutionary new design of a single-dose liquid medication dispensing device for a $93 million market nationwide.
“We take our job personally and we realize we don’t make drugs for faceless patients," Chastain said. “This is a case where the experience of a family member resulted in a new product that will make the medication experience better and for everyone.”
About The Ritedose Corporation
Founded in 1995 and headquartered in Columbia, S.C., The Ritedose Corporation ("Ritedose") is a leading sterile pharmaceutical manufacturer, specializing in the use of blow-fill-seal (BFS) technology. Ritedose provides outsourced development and manufacturing of ophthalmology drugs, respiratory drugs, and vaccines. In addition, Ritedose develops and markets its own portfolio of generic drugs and is an emerging player in the outsourced sterile compounding market focusing on medically necessary drugs that are in short supply. Ritedose customers range from small start-ups and large pharmaceutical companies to wholesalers, retail pharmacies and hospital systems. Today, the company employs more than 400 people. The company's 25-year track record includes the delivery of more than 8 billion doses since 2012 without a single recall, and its current capacity is over 2.0 billion units annually.
SuredoseRx™ single-dose med dispenser
Earlier this month, Pfizer (NYSE: PFE) announced a deal with Biohaven Pharmaceutical (NYSE: BHVN), paying it $500 million ($150 million in cash and $350 million for a 3% stake in Biohaven) in exchange for the rights to market and commercialize two of Biohaven's migraine drugs outside of the United States. Pfizer will also pay double-digit royalties to Biohaven on Nurtec ODT as well as up to $740 million based on future milestones.
'There's a half-life to these protests and boycotts,' said Columbia University marketing professor Mark Cohen, referring to people canceling their Spotify subscriptions.
Walk the walk, baby. If you reject the jab, reject the hospital bed as well. I mean, if you’re going to commit, then commit all the way.
As a profitable and rapidly growing biotech with a world-renowned vaccine approved for sale, BioNTech (NASDAQ: BNTX) has left its shareholders sitting pretty. Over the past 12 months, the company — based in Mainz, Germany — achieved a return of around 41.4%, crushing the market's 14.6% result. More outperformance might well be in the cards for the stock, and there's a lot more to this company than its coronavirus vaccine.
Jenna Miller/TwitterThe X-rays showed that COVID had trashed Trevor Henlsey’s lungs, and the seventh grader was still struggling to breathe after nine days on maximum oxygen in a Missouri pediatric intensive care unit in early November.“Something you never want to hear your child say is, ‘I feel like I’m going to die,’” his mother, Deb Hensley later told The Daily Beast.Over the next three months, her sweet-natured son would wage a ferocious fight for his life. Even with the efforts of a remarka
Fast-food chains like McDonald's and KFC want to sell consumers plant-based meat. But does that make fast food any healthier or environmentally friendly?
The biotech faces stiffer competition and growing pains as it makes a transition to a postpandemic vaccine market. Its big pile of cash should help.
The “All My Children” icon, who celebrated her 75th birthday on Dec. 23, said she does Pilates six days a week.
As Omicron spreads rapidly across the U.S. and millions of Americans have caught the contagious virus, it seems like there's no safe way to avoid the COVID variant. While we all have pandemic fatigue, staying vigilant and taking precautions is key to helping prevent Omicron. Eat This, Not That! Health talked to experts who revealed the seven places you're most likely to get Omicron and where to avoid if possible. Read on—and to ensure your health and the health of others, don't miss these Sure S
N95 masks can provide increased protection against COVID-19 variants like omicron. Here's where to buy N95 masks online from 3M, Project N95 and more.
It's not always COVID-19 that will cause you to feel sick. Here's what other viruses are going around in Sioux Falls.
Stores like CVS, Walgreens, Giant Eagle and more are awaiting shipments of N95 masks to distribute freely to the public in the coming weeks.
Healthcare, the nation's fastest-growing industry, could be next in the push for laws to expand gig work.
You already know olive oil is fantastic for your health. Now, there's even more evidence to support its heart, brain and whole-body benefits.
In a recent special edition, National Geographic did a deep-dive into the Blue Zones. The Blue Zones include five different communities across the globe that are known for having the highest concentration of residents living to be over 100. These zones, researched in-depth by author Dan Buettner, include Ikaria in Greece, Okinawa in Japan, Sardinia in Italy, Loma Linda in California, and the Nicoya Peninsula in Costa Rica.What's particularly interesting about Buettner's research is the breakdown
Víctor Villalobos Moreno found that the simple acts of walking and tracking calories could help turn around a lifetime of challenges and extra weight due to hemophilia.
Life after 60 can be full of wonder, fun, excitement and pleasure—and also peril. Around ever corner lurks a new danger, one you may have defeated soundly when you were younger. But now? Now you're a bit more vulnerable. How to stay young and vital? Don't make the following mistakes, say the nation's leading health experts. Read on for 5 of the most important—and to ensure your health and the health of others, don't miss these Sure Signs You've Already Had COVID. 1 Don't Ignore These Signs of De
Check out these surprising facts about your heart, as well as advice from a top cardiologist to keep it going strong for life.
‘Every person is allowed up to three free masks pending availability,’ Health Department says
Omicron, the highly contagious coronavirus variant sweeping across the country, is driving the daily American death toll higher than during last fall's delta wave, with deaths likely to keep rising for days or even weeks. Now omicron is estimated to account for nearly all the virus circulating in the nation. “Omicron will push us over a million deaths,” said Andrew Noymer, a public health professor at the University of California, Irvine.